Group One Trading
TXMD icon

Group One Trading’s TherapeuticsMD TXMD Stock Holding History

Group One Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,000
Closed -$3.44K – 8398
2024
Q4 		$3.44K Hold
4,000
– – ﹤0.01% 6575
2024
Q3 		$6.64K Hold
4,000
– – ﹤0.01% 5775
2024
Q2 		$6.44K Hold
4,000
– – ﹤0.01% 5842
2024
Q1 		$9.16K Sell
4,000
-13,000
-76% -$30.1K ﹤0.01% 5918
2023
Q4 		$38.3K Buy
17,000
+4,700
+38% +$11.3K ﹤0.01% 5272
2023
Q3 		$37.1K Buy
12,300
+2,000
+19% +$7.57K ﹤0.01% 5375
2023
Q2 		$42.4K Sell
10,300
-54,700
-84% -$215K ﹤0.01% 5404
2023
Q1 		$244K Sell
65,000
-5,800
-8% -$27.8K ﹤0.01% 3483
2022
Q4 		$396K Buy
70,800
+9,900
+16% +$58.3K ﹤0.01% 3255
2022
Q3 		$404K Sell
60,900
-38,600
-39% -$313K ﹤0.01% 3445
2022
Q2 		$990K Buy
99,500
+98,074
+6,878% +$937K ﹤0.01% 2765
2022
Q1 		$27K Sell
1,426
-578
-29% -$9.09K ﹤0.01% 6561
2021
Q4 		$36K Buy
2,004
+122
+6% +$3.66K ﹤0.01% 6566
2021
Q3 		$70K Sell
1,882
-54
-3% -$2.4K ﹤0.01% 6264
2021
Q2 		$115K Sell
1,936
-1,682
-46% -$102K ﹤0.01% 5822
2021
Q1 		$242K Buy
3,618
+1,468
+68% +$115K ﹤0.01% 4829
2020
Q4 		$130K Buy
2,150
+16
+0.7% +$1.09K ﹤0.01% 4379
2020
Q3 		$169K Buy
2,134
+32
+2% +$2.55K ﹤0.01% 3801
2020
Q2 		$131K Buy
2,102
+144
+7% +$8.38K ﹤0.01% 3707
2020
Q1 		$104K Sell
1,958
-1,604
-45% -$159K ﹤0.01% 3268
2019
Q4 		$431K Buy
3,562
+2,018
+131% +$290K ﹤0.01% 2554
2019
Q3 		$280K Buy
1,544
+254
+20% +$35.8K ﹤0.01% 2828
2019
Q2 		$168K Sell
1,290
-62
-5% -$11.1K ﹤0.01% 2991
2019
Q1 		$329K Sell
1,352
-14
-1% -$3.7K ﹤0.01% 2291
2018
Q4 		$260K Sell
1,366
-148
-10% -$36.1K ﹤0.01% 2480
2018
Q3 		$497K Buy
1,514
+702
+86% +$215K ﹤0.01% 2284
2018
Q2 		$253K Buy
812
+32
+4% +$9.78K ﹤0.01% 2870
2018
Q1 		$190K Sell
780
-1,464
-65% -$411K ﹤0.01% 2833
2017
Q4 		$678K Sell
2,244
-634
-22% -$176K ﹤0.01% 2007
2017
Q3 		$761K Buy
2,878
+2,520
+704% +$729K 0.01% 1760
2017
Q2 		$94K Sell
358
-512
-59% -$128K ﹤0.01% 3151
2017
Q1 		$313K Sell
870
-1,818
-68% -$563K ﹤0.01% 2205
2016
Q4 		$775K Buy
2,688
+2,666
+12,118% +$826K 0.01% 1477
2016
Q3 		$7K Sell
22
-38
-63% -$13.9K ﹤0.01% 4149
2016
Q2 		$26K Sell
60
-126
-68% -$51.9K ﹤0.01% 3675
2016
Q1 		$60K Sell
186
-2,862
-94% -$976K ﹤0.01% 3158
2015
Q4 		$1.58M Buy
3,048
+1,574
+107% +$581K 0.02% 1015
2015
Q3 		$432K Buy
1,474
+148
+11% +$52.6K 0.01% 1894
2015
Q2 		$521K Buy
1,326
+594
+81% +$210K 0.01% 1750
2015
Q1 		$221K Buy
732
+712
+3,560% +$174K ﹤0.01% 2295
2014
Q4 		$4K Sell
20
-406
-95% -$83.7K ﹤0.01% 4558
2014
Q3 		$99K Buy
426
+412
+2,943% +$104K ﹤0.01% 3002
2014
Q2 		$3K Buy
14
+8
+133% +$1.78K ﹤0.01% 4933
2014
Q1 		$2K Buy
+6
New +$1.91K ﹤0.01% 5005

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TXMD Position: Q1 2026 in Review

Group One Trading reduced its TherapeuticsMD (TXMD) stake by 100% in Q1 2026, selling an estimated $3.58K and leaving 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #7479.

Group One Trading first reported a position in TXMD in Q2 2014 and has held it in 33 quarters since. The position peaked at $1.48M in Q3 2018. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Group One Trading held 2 shares of TherapeuticsMD worth $4 as of Q1 2026.
  • Group One Trading sold 1,594 TherapeuticsMD shares in Q1 2026, an estimated $3.58K.
  • TherapeuticsMD made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7479 holding.
  • Group One Trading first reported a position in TherapeuticsMD in Q2 2014 and has held it in 33 quarters since.
  • Group One Trading's TherapeuticsMD position peaked at $1.48M in Q3 2018.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.